Revenue - Products Sales was the largest of TFA Therapeutics, Inc.’s 2 reported lines in fiscal 2025, at $1.07M — 86% of $1.25M.
| Product and Service | FY 2020 | FY 2021 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue - Products Sales | $601.57K | $1.20M | $1.07M | ||
| Sales Of Cordyceps | — | — | — | ||
| Revenue - Training | $154.11K | — | — | ||
| Revenue - Related Parties | $126.86K | $52.94K | $175.41K | ||
| Training Of Cordyceps Cultivation | — | — | — | ||
| Total | $882.53K | $1.25M | $1.25M |
In fiscal 2025, which ended December 31, 2025, the 2 revenue lines TFA Therapeutics, Inc. reported in this breakdown added up to $1.25M. That was down 0.6% from $1.25M in fiscal 2024. Revenue - Products Sales was the largest revenue line, at $1.07M or 85.9% of the total, followed by Revenue - Related Parties ($175.41K, 14.1%).
Compared with fiscal 2024, Revenue - Related Parties grew the fastest, rising 231.3% to $175.41K. Revenue - Products Sales fell the most, down 10.9% to $1.07M.
The table also keeps 3 revenue lines that TFA Therapeutics, Inc. no longer reports, so earlier years can still be read on their original basis; use "Show 3 discontinued" beneath the table to see them. This breakdown covers 5 fiscal years between 2020 and 2025, as reported in TFA Therapeutics, Inc.'s annual filings.
TFA Therapeutics, Inc. (RAJAF) breaks its revenue down by revenue line. In fiscal 2025, its largest revenue line was Revenue - Products Sales, with $1.07M or 85.9% of the total, followed by Revenue - Related Parties at $175.41K (14.1%).
Revenue - Products Sales was TFA Therapeutics, Inc.'s largest revenue line in fiscal 2025, with $1.07M in revenue, 85.9% of the $1.25M reported across its 2 revenue lines.
Of the TFA Therapeutics, Inc. revenue lines reported in both fiscal 2024 and fiscal 2025, and making up at least 2% of the total, Revenue - Related Parties grew the fastest, rising 231.3% from $52.94K to $175.41K.
Every figure is taken from TFA Therapeutics, Inc.'s annual financial filings and shown as reported: each line keeps the name the company gives it, years follow its own fiscal calendar, and lines it has stopped reporting stay in the table for the years they were reported.
The breakdown by revenue line covers fiscal 2020 to 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.